We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Paradoxical Lucidity Could Help Explain Dementia Pathophysiology

By HospiMedica International staff writers
Posted on 10 Jul 2019
Print article
A new study outlines what is known and unknown about paradoxical lucidity, the phenomena of unexplained clarity that many dementia patients experience at end of life.

Researchers at Duke University (Durham NC, USA), the University of Pennsylvania (Philadelphia, PA, USA), and other institutions participating in an interdisciplinary workgroup convened by the U.S. National Institute on Aging (Bethesda, MD, USA) conducted a study to review what is known about paradoxical lucidity, related phenomena that provide insight into potential mechanisms, ethical implications, and methodologic considerations for systematic investigation.

The study describes earlier work documenting case studies of individuals with advanced dementia, including Alzheimer's disease (AD), appearing to be able to communicate with their family and recall in a seemingly normal fashion at the end of life, to the astonishment of their caregivers. The researchers warned, however, that studying paradoxical lucidity would be a challenge, given the fleeting nature of the event, with case studies reporting episodes lasting from mere seconds to at most several days in a small minority of cases.

The researchers conclude that paradoxical lucidity, if systematically confirmed, challenges current assumptions and highlights the possibility of network-level return of cognitive function in cases of severe dementias, which can provide insight into both underlying neurobiology and future therapeutic possibilities. The workgroup also outlined ethical implications, including the ability of vulnerable patients to participate in research, and how observation of paradoxical lucidity might change the way caregivers interact with people with dementia. The study was published in the August 2019 issue of Alzheimer's & Dementia.

“We've assumed that advanced dementia is an irreversible neurodegenerative process with irreversible functional limitations,” said lead author Professor George Mashour, MD, PhD, director of the Center for Consciousness Science at Duke University. “But if the brain is able to access some sort of functional network configuration during paradoxical lucidity, even in severe dementia, this suggests a reversible component of the disease.”

“Would research that might identify a systematically observable paradoxical lucidity provide comfort, for example, by offering loved ones a potential channel for closure, or might it induce worry if loved ones are left to wonder if a reversible cause of the dementia could have been found?” said co-first author Lori Frank, PhD, of the RAND Corporation (Pittsburgh, PA, USA), and former Health and Aging Congressional fellow with the National Institute on Aging. “We do not know the answers but these could be important research questions in their own right.”

Related Links:
Duke University
University of Pennsylvania
U.S. National Institute on Aging
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Surgical Table
STERIS 5085 SRT

Print article

Channels

Surgical Techniques

view channel
Image: The FieldForce Catheter is the first and only contact force PFA catheter optimized for the ventricles (Photo courtesy of Field Medical)

First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias

It is estimated that over 6 million patients in the US and Europe are affected by ventricular arrhythmias, which include conditions such as ventricular tachycardia (VT) and premature ventricular contractions (PVCs).... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more